Insights

OTC Growth Innovus has a focus on over-the-counter and consumer health care products for home treatment, presenting ongoing sales opportunities with retailers, distributors, and private-label partners seeking mainstream wellness solutions.

Significant Reach With a presence in Canadian markets and a diversified product line spanning vitality, sexual health, pain relief, respiratory care, and reproductive health, there are cross-sell opportunities across geographies and category extensions.

Strategic Partnerships Past and ongoing licensing, acquisitions, and co-development activity indicate openness to collaborations, licensing deals, and co-branding with manufacturers or distributors to accelerate market access.

Co-Branding Potential New product launches like OmepraCare and UriVarx suggest a flexibility for brand partnerships or white-label opportunities with existing OTC channels and pharmacy networks seeking differentiated SKUs.

Funding & Scale Current revenue range and modest funding imply opportunities for growth capital, channel expansion, and strategic investments to scale manufacturing, distribution, and marketing for larger market presence.

Innovus Pharmaceuticals Tech Stack

Innovus Pharmaceuticals uses 8 technology products and services including RSS, Open Graph, jQuery, and more. Explore Innovus Pharmaceuticals's tech stack below.

  • RSS
    Content Management System
  • Open Graph
    Content Management System
  • jQuery
    Javascript Libraries
  • Facebook Share Button
    Miscellaneous
  • PayPal
    Payment Processing
  • X-XSS-Protection
    Security
  • UIKit
    UI Frameworks
  • Facebook
    Widgets

Media & News

Innovus Pharmaceuticals's Email Address Formats

Innovus Pharmaceuticals uses at least 1 format(s):
Innovus Pharmaceuticals Email FormatsExamplePercentage
FLast@innovuspharma.comJDoe@innovuspharma.com
100%

Frequently Asked Questions

What is Innovus Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Innovus Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Innovus Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals is a publicly traded company; the company's stock symbol is INNV.

What is Innovus Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's official website is innovuspharma.com and has social profiles on LinkedInCrunchbase.

What is Innovus Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Innovus Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of July 2026, Innovus Pharmaceuticals has approximately 5 employees across 3 continents, including North AmericaAfricaAsia. Key team members include Executive Vice President: R. R.. Explore Innovus Pharmaceuticals's employee directory with LeadIQ.

What industry does Innovus Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Innovus Pharmaceuticals use?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's tech stack includes RSSOpen GraphjQueryFacebook Share ButtonPayPalX-XSS-ProtectionUIKitFacebook.

What is Innovus Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals's email format typically follows the pattern of FLast@innovuspharma.com. Find more Innovus Pharmaceuticals email formats with LeadIQ.

How much funding has Innovus Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of July 2026, Innovus Pharmaceuticals has raised $1.6M in funding. The last funding round occurred on Feb 25, 2014 for $6.5M.

When was Innovus Pharmaceuticals founded?

Minus sign iconPlus sign icon
Innovus Pharmaceuticals was founded in 2011.
Innovus Pharmaceuticals logo

Innovus Pharmaceuticals

Pharmaceutical ManufacturingNevada, United States2-10 Employees

Innovus Pharmaceuticals is a pharmaceutical manufacturing company based in Reno, Nevada, with a small workforce of 2 to 10 employees. The company focuses on in-licensing, acquiring, or developing over-the-counter and consumer health care products intended for at-home treatment of medical conditions. Its product scope covers vitality, sexual health, muscle and joint pain, reproductive health, respiratory issues, and general supportive care for both men's and women's health. The company has announced several product launches, including FlutiCare fluticasone propionate nasal spray in November 2017, AllerVarx for allergic rhinitis in Canada in June 2018, Diabasens in Canada in March 2019, and UriVarx UTI strips launched in 2020 under an agreement with ACON Laboratories. The company maintains a website at innovuspharma.com.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
INNV
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2011
Employees
2-10

Section iconFunding & Financials

  • $1.6M

    Innovus Pharmaceuticals has raised a total of $1.6M of funding over 3 rounds. Their latest funding round was raised on Feb 25, 2014 in the amount of $6.5Mas a post_ipo_equity.

  • $1M$10M

    Innovus Pharmaceuticals's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1.6M

    Innovus Pharmaceuticals has raised a total of $1.6M of funding over 3 rounds. Their latest funding round was raised on Feb 25, 2014 in the amount of $6.5Mas a post_ipo_equity.

  • $1M$10M

    Innovus Pharmaceuticals's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.